20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine." A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
Integra Lifesciences (NASDAQ:IART) reported its Q3 earnings results on Wednesday, October 26, 2022 at 06:00 AM.
Here's what investors need to know about the announcement.
Earnings
Integra Lifesciences beat estimated earnings by 17.81%, reporting an EPS of $0.86 versus an estimate of $0.73.
Revenue was down $1.67 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.02 which was followed by a 0.42% drop in the share price the next day.
Here's a look at Integra Lifesciences's past performance:
| Quarter | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|
| EPS Estimate | 0.80 | 0.68 | 0.83 | 0.72 |
| EPS Actual | 0.82 | 0.74 | 0.84 | 0.86 |
| Revenue Estimate | 395.27M | 362.04M | 403.40M | 384.58M |
| Revenue Actual | 397.81M | 376.64M | 405.52M | 386.86M |
To track all earnings releases for Integra Lifesciences visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine." A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!